Insulet to Announce Second Quarter 2021 Financial Results on August 5, 2021

Rhea-AI Summary

Insulet Corporation (NASDAQ: PODD), a leader in tubeless insulin pump technology, will release its financial results for Q2 2021 on August 5, 2021, after market close. A conference call is scheduled for the same day at 4:30 p.m. Eastern Time. The Omnipod Insulin Management System continues to innovate in diabetes management, providing up to three days of insulin delivery without the need for needles.

Positive

• Plans to release Q2 2021 financial results on August 5, 2021.
• Continuous innovation with the Omnipod Insulin Management System.

Negative

• None.

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod^® brand of products, today announced plans to release its financial results for the second quarter of 2021 on August 5, 2021 after the close of the financial markets. In connection with the release, management will host a conference call that day at 4:30 p.m. (Eastern Time).

The link to the live call will be available on the Investor Relations section of the Company's website at http://investors.insulet.com, “Events and Presentations,” and will be archived for future replay. You may also access the live call by dialing (844) 831-3022 for domestic callers or (315) 625-6887 for international callers, passcode is 1592280.

About Insulet Corporation:

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit: www.insulet.com and www.omnipod.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210701005015/en/

FAQ

What date will Insulet Corporation release its Q2 2021 financial results?

Insulet Corporation will release its Q2 2021 financial results on August 5, 2021.

What is the significance of the Omnipod product platform?

The Omnipod product platform simplifies insulin delivery for diabetes management with its tubeless design, offering up to three days of non-stop insulin delivery.

What time is the conference call for Insulet's Q2 results?

The conference call for Insulet's Q2 results is scheduled for 4:30 p.m. Eastern Time on August 5, 2021.

How can I access the live call for Insulet Corporation's financial results?

The live call can be accessed via the Investor Relations section of Insulet's website or by dialing (844) 831-3022 for domestic callers and (315) 625-6887 for international callers.